Elucidation of pathological mechanism caused by human disease mutation in CaMKIIβ

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• CaMKIIα and CaMKIIβ mutations are linked to neurodevelopmental disorders.
• Cell culture studies suggest CaMKII mutants exhibit increased autonomous activity due to enhanced Thr286/287 phosphorylation.

Purpose of the Study:

• To investigate the pathological mechanism of motor dysfunction in a patient with a CaMKIIβ Pro213Leu mutation.
• To develop and characterize a mouse model for this specific CaMKIIβ mutation.

Main Methods:

• Generated homozygous CaMKIIβ Pro213Leu knockin mice.
• Assessed motor function, growth, and CaMKIIβ expression and phosphorylation in the cerebellum.
• Compared phenotypes with CaMKIIβ knockout mice and the human patient.

Main Results:

• CaMKIIβ Pro213Leu knockin mice displayed age-dependent motor deficits and growth failure.
• Cerebellar CaMKIIβ protein levels were significantly reduced, while mRNA levels remained unchanged.
• Contrary to cell culture findings, Thr287 phosphorylation of CaMKIIβ was decreased in vivo.
• The observed motor dysfunction resembled that of CaMKIIβ knockout mice, suggesting a loss-of-function mechanism.

Conclusions:

• The Pro213Leu mutation in CaMKIIβ causes motor dysfunction through a reduction in functional CaMKIIβ protein in the brain.
• This study highlights significant differences in the physiological consequences of CaMKIIβ mutations between in vitro cell culture and in vivo mouse models.
• The mouse model recapitulates key patient phenotypes, excluding epileptic seizures, and provides evidence for a loss-of-function mechanism in neurodevelopmental disorders.